When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Technology Letter November 8, 2023 Fiat Lux Featured Trade: (SETTING UP FOR THE NEXT BULL MARKET) (WEWKQ)
Taking out long-term leases and turning around to rent short-term i.e. Airbnb style for corporate offices ended with a thud as office sharing tech company WeWork filed for bankruptcy. The idea never made sense and felt more like a gimmick. Surprisingly, this bankruptcy didn’t happen much earlier as the “work from home” pivot during 2020-2022
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
(IT’S A GREEN LIGHT FOR THE MARKET ACCORDING TO THIS INDICATOR) November 8, 2023 Hello everyone, A reliable and rare market indicator is flashing green meaning we may well see good times on Wall Street for the next 12 months. This market indicator is called the Zweig Breadth Thrust. It flashed a buy
Global Market Comments November 8, 2023 Fiat Lux (I HAVE A NEW OPENING FOR THE MAD HEDGE FUND TRADER CONCIERGE SERVICE), (TESTIMONIAL), (RIGHT SIZING YOUR TRADING)
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Biotech and Healthcare Letter November 7, 2023 Fiat Lux Featured Trade: (OUTSMARTING OPIOIDS) (VRTX), (LLY), (NVO), (BIIB)
Amid the stark realities of America's opioid crisis, with a staggering 80,000 annual fatalities due to overdose, the pharmaceutical industry is on the brink of a significant shift. Vertex Pharmaceuticals (VRTX) stands out with its investigational drug VX-548, which promises a novel approach to pain management without the addiction risks of opioids. As the year
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.